Xue-Yan JIANG Consultant Clinical Oncologist Newcastle

Xue-Yan JIANG Consultant Clinical Oncologist Newcastle

Xue-Yan JIANG Consultant Clinical Oncologist Newcastle delivers expert care for patients with urological cancers. She works at the Northern Centre for Cancer Care (NCCC) at the Freeman Hospital, where she provides personalized treatment plans for prostate, kidney, and bladder cancers. Her dedication to patient care drives every step of her clinical work.

Medical Background and Qualifications

Dr Xue-Yan Jiang began her medical journey at Newcastle University, graduating in 2008. She also holds both a BSc and an MSc in Biomedical Science from Northumbria University. Her deep academic foundation ensures she delivers the highest standard of care to every patient. After completing Specialist Training in Clinical Oncology at NCCC, she became a Consultant in 2020. This journey reflects her commitment to excellence in oncology.

Specialist Expertise in Urological Cancers

As a dedicated clinical oncologist, Dr Jiang focuses on the treatment of prostate, kidney, and bladder cancers. Her expertise in radiotherapy and systemic therapy allows her to tailor treatment approaches to each patient. This patient-centered approach ensures that every decision prioritizes both quality of life and treatment effectiveness.

Research, Teaching, and Clinical Leadership

Xue-Yan JIANG Consultant Clinical Oncologist Newcastle actively contributes to research in radiotherapy, imaging, bone health, and biomarkers. Her work supports ongoing advances in cancer treatment. Alongside her research, she mentors junior doctors and Advanced Clinical Practitioners (ACPs) as both a clinical and educational supervisor. This role strengthens the future of oncology care while improving patient outcomes.

Commitment to Excellence in Cancer Care

Dr Jiang’s work at the Northern Centre for Cancer Care combines expert clinical practice with active research and teaching. Her leadership in urological oncology reflects a clear mission: to provide exceptional care while advancing cancer treatment for future patients.